[Clinical development of antimycotics. Medical challenges].
Lipp
Hans-Peter
HP
Universitätsapotheke Tübingen Röntgenweg 9, 72076 Tübingen. hans-peter.lipp@med.uni-tuebingen.de
D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D000077336:Caspofungin; D004337:Drug Carriers; D054714:Echinocandins; D005079:Excipients; D005658:Fungi / Q000187:drug effects*; D006801:Humans; D017964:Itraconazole / Q000008:administration & dosage / Q000627:therapeutic use; D055666:Lipopeptides; D008081:Liposomes; D010455:Peptides; D010456:Peptides, Cyclic; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use; D012106:Research; D014230:Triazoles / Q000008:administration & dosage / Q000627:therapeutic use; D065819:Voriconazole
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D004337:Drug Carriers; D054714:Echinocandins; D005079:Excipients; D055666:Lipopeptides; D008081:Liposomes; D010455:Peptides; D010456:Peptides, Cyclic; D011743:Pyrimidines; D014230:Triazoles; D017964:Itraconazole; D000666:Amphotericin B; D000077336:Caspofungin; D065819:Voriconazole